您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Indinavir
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Indinavir
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Indinavir图片
CAS NO:150378-17-9
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
茚地那韦
MK-639 free base
L-735524 free base
产品介绍
Indinavir (MK-639 free base) 是一种口服有效并且具有选择性的HIV-1蛋白酶抑制剂,其对PRKi值为 0.54 nM。Indinavir 可通过抑制基质金属蛋白酶-2 水解的激活,抗血管生成以及促癌细胞凋亡来发挥抗癌活性。Indinavir 也是一种SARS-CoV 3CLpro抑制剂。
生物活性

Indinavir (MK-639 free base) is an orally active and selectiveHIV-1proteaseinhibitor with aKiof 0.54 nM forPR. Indinavir exhibits anticancer activity by inhibiting the activation ofMMPs-2hydrolysis, anti-angiogenesis and inducingapoptosis. Indinavir is also aSARS-CoV3CLproinhibitor[1][2][3][4].

IC50& Target

HIV-1

 

MMP-2

 

体外研究
(In Vitro)

Indinavir (0-50 μM; 18 h) blocks lymphocyte cell cycle in G0/G1 phase in PBMCs cells and impairs lymphoproliferative responses[1].
Indinavir (40 μM-40 nM; 5 days) inhibits cell invasion and (40 μM-40 nM; 48 h) MMPs-2 activation of the Huh7 and SK-HEP-1 hepatocarcinoma cells in vitro[2].

Cell Viability Assay[1]

Cell Line:PBMCs (from healthy and HIV-infected volunteers)
Concentration:0-50 μM
Incubation Time:18 h (pretreatment; stimulation with anti-CD3 for an additional 48 hours)
Result:Blocked anti-CD3-induced cell-cycle progression in a dose-dependent manner.
Resulted in dose-dependent reduction of lymphoproliferative responses.

Cell Invasion Assay[2]

Cell Line:Huh7 and SK-HEP-1 cells
Concentration:40 μM-40 nM
Incubation Time:5 days
Result:Reduced ability to invade an in vitro constituted extracellular matrix for both cell lines treated compared with the untreated cells.

Western Blot Analysis[2]

Cell Line:Huh7 and SK-HEP-1 cells
Concentration:40 μM-40 nM
Incubation Time:48 h
Result:Blocked the conversion of latent MMP-2 to its 62/64-kDa active form.
体内研究
(In Vivo)

Indinavir (70 mg/kg; i.g.; once a day for 3 weeks) inhibits the growth of hepatocarcinoma cells in vivo[2].

Animal Model:Nude mice(s.c. into Huh7 and SK-HEP-1 cells)[2].
Dosage:70 mg/kg
Administration:Oral gavage; once a day for 3 weeks.
Result:Delaied the growth of s.c. implanted hepatocarcinoma xenografts in nude mice compared with placebo.
Clinical Trial
分子量

613.79

Formula

C36H47N5O4

CAS 号

150378-17-9

中文名称

茚地那韦;吲地纳韦;英地那韦;印地那韦;茚地那维

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.